Most of our sales are going to people who trust the brand and know very little about the underlying science, if anything. Yes there are new competitors but to date none of them are making even a dent in our sales. Furthermore the company has welcomed competitors to help spread the value of the a2 proposition. Also brands command premiums, not the product - our brand is quickly becoming the most recognised IF brand in China and as competitors have come on board our premium has actually increased- twice!
Most of our sales are going to people who trust the brand and...
-
- There are more pages in this discussion • 190 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.45 |
Change
0.640(13.3%) |
Mkt cap ! $3.808B | |||
| Open | High | Low | Value | Volume |
| $5.59 | $5.72 | $5.38 | $59.39M | 10.71M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 50150 | $5.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.45 | 77730 | 4 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |
